Opinion: Redefining Productivity in the Age of COVID-19

We mourned the closing of our lab. But then we got back to work—finding the balance between scholarly relevance and adapting to life in a world of new social norms.

Written bySadye Paez and Erich Jarvis
| 6 min read
erich jarvis coronavirus pandemic covid-19 sars-cov-2 producivity lab closure rockefeller university

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

ABOVE: The empty Jarvis lab on the day it closed
ERICH JARVIS

It is Wednesday afternoon, March 18, 2020, a beautiful day hinting at spring, the cherry blossoms beginning to bloom. The city that never sleeps is restless, with many of its 8.6 million residents either incredulous about the growing urgency of the COVID-19 pandemic or fully committed to preparing for quarantined life indoors, a seeming impossibility here where domestic life typically spills out onto front stoops and into city parks and crowded restaurants. In Manhattan, one sacrifice among the millions that residents are making unfolds. One of us (EDJ) tweets, “The first time I have to close my lab in 22 years. The COVID-19 pandemic is affecting us all in many ways. Let’s all be part of the solution.” Our institution, the Rockefeller University, officially closed that day.

The decree by our university and city to shut down all non-essential ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies